| 1.1   | "Change      of Control" shall mean the assignment, or other transfer that effects the      same however titled by LICENSEE, to a third party of this License between      UA and LICENSEE. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.2   | "Effective      Date" shall be the last date of signature by authorized representatives of      the two parties affirming acceptance of the terms and conditions of this      Agreement. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.3   | “Field      of Use” shall mean Organic Light-Emitting Diodes in printed electronic      displays and all other printed electronic  components. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 1.4   | “Licensed      Method” shall mean any method that: |
|-----------------|----------------------------------------------------------------|

| 1.4.a   | Is      covered by Patent Rights, the use of which would constitute but for the      license granted to LICENSEE under this Agreement, an infringement of any      issued claim of Patent Rights (including, but not limited to, inducement      or contributory infringement); or |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.4.b   | Incorporates      or is created from access to Technical Information which has provided      LICENSEE the time advantage of information and hence a springboard to the      business activities of LICENSEE. |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.5   |  “Licensed      Product” shall mean any productthat: |
|-----------------|-----------------------------------------------------------------------|

| 1.5.a   | Is      covered by Patent Right or is produced by the Licensed Method, to the      extent that the production, use, or sale of such product would infringe an      issued claim of Patent Rights (including, but not limited to, inducement      or contributory infringement), but for the license granted to LICENSEE      under this Agreement or that is produced by the Licensed Method;      or |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.5.b   | Incorporates      or is created from access to Technical Information which has provided      LICENSEE the time advantage of information and hence a springboard to the      business activities of LICENSEE. |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.6   | "Net      Sales" shall mean the total of the gross invoice prices from the sale of      Licensed Product or the performance of Licensed Method or Licensed Service      by COMPANY, or a sublicensee, to any third parties for cash or other forms      of consideration.  COMPANY may make the following deductions, at      rates customary within the industry (if not already deducted from the      gross invoice price), when calculating the total gross invoice      prices: |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.6.a   | allowances      actually paid and limited to rejections, returns, and prompt payment and      volume discounts granted to customers of LICENSEE, or a      sublicensee; |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.6.b   | freight,      transportation, packing, and/or insurance charges actually paid associated      with transportation; |
|-------------------|--------------------------------------------------------------------------------------------------------------------|

| 1.6.c   | taxes      based on sales when included in gross sales, but not taxes assessed on      income derived from such sales; and |
|-------------------|----------------------------------------------------------------------------------------------------------------------------|

|   | Where LICENSEE distributes Licensed Products for end use to      itself or a sublicensee, for purposes other than research and development,      then such distribution will be considered a sale at the list price      normally charged to independent third parties, and UNIVERSITY will be      entitled to collect royalty on such a sale in accordance with Article      3.  Subsequent distribution or sale of these Licensed Products      from LICENSEE or sublicensee shall not be subject to additional      royalties. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.7   | “Patent      Rights” shall mean U.S. Patent No. 7,015,052, issued on March 21, 2006,      entitled "Screen-Printing Techniques for the Fabrication of Organic      Light-Emitting Diodes." |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.8   |  “Prior      Patent Costs” shall mean direct out of pocket costs incurred by UNIVERSITY      for the perfection of Patent Rights prior to the Effective Date which      currently total $9280.76. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 1.9   | “Sublicensing      Consideration” shall mean all consideration received by LICENSEE for the      grant of a sublicense of any of the rights granted to LICENSEE under this      Agreement, including but not limited to upfront license fees, minimum      annual payments, license maintenance payments, milestone payments, royalty      and equity interest in the acquirer above the fair market value of the      interest transferred.  Sublicensing Consideration excludes      Running Royalties and direct payments to LICENSEE for research projects      advancing Licensed Product or Licensed Methods and detailed in advance by      a research plan and commensuratebudget. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.10   | “Technical      Information” shall mean UNIVERSITY's information and know-how represented      by: |
|------------------|----------------------------------------------------------------------------------------------------------------|

| 1.10.a   | the      information content of items made available to LICENSEE under this      Agreement in tangible form, including without limitation prototypes,      documented processes or techniques, written procedures or methods,      protocols, patent applications, software, data compilations or UNIVERSITY      invention disclosure files as inventoried in Exhibit A or otherwise      identified in this Agreement, whether provided prior to or after the      Effective Date of this Agreement;or |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.10.b   | services      by UNIVERSITY or UNIVERSITY employees acting as consultants with      UNIVERSITY’s approval that teach or transfer to LICENSEE UNIVERSITY      information associated with Article 1.10.a;or |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.10.c   | transfers      of UNIVERSITY personnel to LICENSEE that teach or transfer to LICENSEE      UNIVERSITY information associated with Article  1.10.a. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.11   | “Territory”      for Technical Information shall mean worldwide; and for Patent Rights      shall mean those countries for which Patent Rights have been perfected and      are being maintained in accordance with Article  5. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.1   | License Grant – Patent Rights.      UNIVERSITY grants to LICENSEE upon receipt of Prior Patent Costs      and the License Issue Fee as set forth in Article 3, and LICENSEE accepts,      an exclusive license to UNIVERSITY’s interest in valuable intangible      property rights in Patent Rights to make, have made, import, have      imported, use, market, sell, and distribute Licensed Product, and practice      Licensed Method within the Field of Use and in the      Territory.  These rights are specifically subject to Paragraphs      2.4, 2.5 and 2.6 as well as the general terms and conditions set forth in      this Agreement.  This grant does not relinquish UNIVERSITY      ownership in or rights to Technical Information or Patent Rights and does      not grant, by implication or otherwise, any other rights to LICENSEE of      any other technologies owned, invented, or discovered by UNIVERSITY,      whether past, present, or future. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.2   | License Grant – Technical      Information. UNIVERSITY grants to LICENSEE upon receipt of Prior      Patent Costs and the License Issue Fee as set forth in Article 3, and      LICENSEE accepts, a nonexclusive license to Technical Information to make,      have made, import, have imported, use, market, sell, and distribute      Licensed Product, and practice Licensed Method within the Field of Use and      in the Territory consistent with the purpose of this Agreement subject to      the confidentiality provisions of Article 9.  These rights are      specifically subordinate to any Patent Right and the need for a grant of      rights thereto as well as subject to Paragraphs 2.4, 2.5 and 2.6 and the      general terms and conditions set forth in this  Agreement. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 2.3   | Sublicensing Grant.      UNIVERSITY grants to LICENSEE as long as LICENSEE possesses an exclusive      right to UNIVERSITY’s interest in Patent Rights under Paragraph 2.1 of      this Agreement, and LICENSEE accepts, the nontransferrable right to issue      to third parties sublicenses with respect to Licensed Product and Licensed      Method within the scope of the grant of rights provided by UNIVERSITY to      LICENSEE in Paragraphs 2.1 and 2.2.  Any and all sublicense      agreements within the Field of Use granted by LICENSEE shall include all      of the rights and obligations contained in this Agreement due UNIVERSITY,      and, if applicable, due the United States  Government. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.4   | General Retained Rights.      UNIVERSITY retains all other rights in Patent Rights and Technical      Information not expressly grantedLICENSEE. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.5   | Specific Retained      Rights. UNIVERSITY retains: |
|-----------------|----------------------------------------------------|

| 2.5.a   | For      its research and educational purposes, the right to practice the      inventions claimed in Patent Rights within the Field of Use and in the      Territory including without limitation UNIVERSITY's right to make, use,      have made, have used, import or have imported the inventions and to      practice Licensed Methods; and |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.5.b   | The      right to maintain and sublicense these same rights in Paragraph 2.5.a      solely for research and educational purposes to other institutions of      higher education or non-profit research  institutions. |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.5.c   | Nothing      in this Agreement limits the right of UNIVERSITY to publish any and all      results and technical data resulting from research performed by      UNIVERSITY, including, but not limited to, research relating to the      Licensed Products, Licensed Method, or Technical    Information. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.6   | Government License. The      development of Technical Information and Patent Rights was sponsored in      part by the U.S. Government, and as a consequence, this Agreement is      subject to overriding obligations to the Federal Government under rights      and limitations of Public Laws (PL) 96-517 and 98-620 and implementing      regulations including 35 USC §§200-211 and 37 CFR Part 401 (“U.S.      Government Rights”), as well as the royalty-free provisions of Paragraph      3.5 and the manufacturing statement of Paragraph  13.5. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | FEES, ROYALTIES AND      PATENT COSTS |
|----|---------------------------------------|

| 3.1   | Royalties.  In      partial consideration for the rights granted herein, LICENSEE shall pay      UNIVERSITY on the schedule described in Article 4 the following      royalties: |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.1.a   | Running Royalties:      Royalties based on Net Sales (the “Running Royalties”)  of: |
|-------------------|-------------------------------------------------------------------------------------------------|

| 3.1.a.i   | Two      Percent (2.0 %) of Net Sales of Licensed Products for Non-Display      Electronic Component applications;and |
|---------------------|-----------------------------------------------------------------------------------------------------------------------|

| 3.1.a.ii   | Two      and one-half Percent (2.5%) of Net Sales of Licensed Products for Printed      Electronic Displays |
|----------------------|-------------------------------------------------------------------------------------------------------------|

----

| 3.1.b   | Minimum Annual      Royalty:  A minimum royalty according to the following      schedule. |
|-------------------|-----------------------------------------------------------------------------------------------------|

| 3.1.b.i   | The      Minimum Annual Royalty payment will be creditable against Royalties due in      each respective royalty year, July 1 to June 30th following the due      date. |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.1.b.ii   | The      Annual Minimum Royalties will be adjusted by the cumulative percentage      change in the CPI-W Consumer Price Index between July  and the      June preceding the date on which the payment in question is      payable. |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.1.c   | Royalties Due From      Sublicenses:  For each sublicense granted by LICENSEE,      LICENSEE shall pay UNIVERSITY on the schedule described in Article 4 the      following royalties : |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.1.c.i   |  Net Sales by      Sublicensees: Running Royalties as set forth in Article      3.1.a. |
|---------------------|---------------------------------------------------------------------------------------------|

| 3.1.c.ii   | Sublicensee Minimum Annual      Royalty: Minimum royalties as set forth in  3.1.b. |
|----------------------|------------------------------------------------------------------------------------|

| 3.1.c.iii   | Sublicensing      Consideration: Fifteen Percent (15%) of Sublicensing Consideration      earned in any period. |
|-----------------------|-----------------------------------------------------------------------------------------------------------------|

| 3.2   | Prior Patent      Costs:  In partial consideration for the rights granted      herein, LICENSEE shall pay any outstanding Prior Patent Costs upon      execution of this Agreement. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.3   | Patent      Costs:  In partial consideration for the rights granted      herein, LICENSEE shall pay within sixty (60) days of receipt of the      UNIVERSTY invoice all costs present and future, incurred in maintaining      Patent Rights. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.4   | License      Fee:  A License Fee of Fifteen Thousand Dollars ($15,000)      shall be paid within 90 days of execution of the  Agreement. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.5   | Early Termination      Fee:  For termination prior to June 30, 2012, Licensee      will pay UA an early termination fee of$75,000. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------|

| 3.6   | Change of      Control:  The lesser of $350,000 or 3.0% of the monetary      value of all consideration from a transaction involving the sale or      assignment or effective transfer of the license agreement to any third      party is due upon execution of the Change of  Control. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.7   | U.S.      Government.   If a Government License exists      according to Paragraph 2.6 and if LICENSEE maintains evidence of sales to      the U.S. government under U.S. Government Rights, then no royalties may be      collected nor need be paid on Licensed Products sold to or Licensed Method      performed for the U.S. Government or any agency thereof, as provided for      in that license to the government. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 4.1   | Timing of Royalty      Payments. LICENSEE shall pay all royalties under Paragraph 3.1      quarterly and within thirty (30) days of the end of each calendar      quarter.  Each such payment shall be for the most recently      completed calendar quarter. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.2   | Sublicense      Reporting.  LICENSEE shall notify the UNIVERSITY of each      sublicense granted hereunder.  LICENSEE shall collect and pay      all fees and royalties due UNIVERSITY and guarantee all such payments due      from sublicensees.  LICENSEE shall monitor sublicensees and      assure license terms are met, appropriate records are kept and product      quality is equal to or greater than that required by this      Agreement. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.3   | Quarterly Royalty      Reports. After the first commercial sale of Licensed Product or      performance of Licensed Method, LICENSEE shall provide UNIVERSITY with an      annual written report within thirty (30) days of December 31 of each      calendar year indicating: |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.3.a   | Quantity      of Licensed Product produced or Licensed Method performed in each      location, relevant information on maintaining Licensed Products quality,      and supplies of Licensed Products held by LICENSEE and sublicensee(s);      and |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.3.b   | Summary      of Licensed Product and Licensed Method gross sales and Net Sales for both      LICENSEE and sublicensee(s); and |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------|

| 4.3.c   | The      royalties due, including the method used to calculate royalties, the      exchange rates used, if applicable, as well as any reductions due to sales      to the U.S. Government; and |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.3.d   | An      accounting of the quantity of Licensed Product sold and Licensed Method      performed by LICENSEE and each sublicensee(s), including a summary of      domestic and international distribution on which royalties are      payable. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.4   | Semi-Annual Pre-commercial      effort reporting. Beginning December 2009 and continuing annually      thereafter, LICENSEE shall submit to UNIVERSITY a progress report within      thirty (30) days of December 31 covering LICENSEE’s activities related to      the development and testing of all Licensed Products and Licensed Methods      and the obtaining of the governmental approvals necessary for production,      marketing, distribution and sale.  Progress reports are required      for each Licensed Product and Licensed Method until the first commercial      sale of that Licensed Product occurs in the United States. Such reports      shall again be required if commercial sales of such Licensed Product or      performance of Licensed Method are suspended or      discontinued.  Progress reports submitted hereunder shall      include, but are not limited to, the following  information: |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.4.a   | Summary      of work completed |
|-------------------|--------------------------------|

| 4.4.b   | Key      scientific discoveries |
|-------------------|---------------------------------|

----

| 4.4.c   | Summary      of work in progress |
|-------------------|----------------------------------|

| 4.4.d   | Current      schedule of anticipated events ormilestones |
|-------------------|----------------------------------------------------------|

| 4.4.e   | Market      plans for introduction of Licensed Products and Licensed      Methods |
|-------------------|-----------------------------------------------------------------------------------|

| 4.4.f   | A      summary of resources (dollar value) spent in the reporting      period. |
|-------------------|--------------------------------------------------------------------------------|

| 4.5   | Payment in U.S. Dollars.      Payments hereunder shall be made in U.S. dollars in the United      States.  If Licensed Products are sold or Licensed Method is      performed for monies other than United States dollars, LICENSEE shall      first determine the earned royalty in the currency of the country in which      Licensed Products were sold or Licensed Method was practiced and then      convert the amount into equivalent United States funds, using the exchange      rate quoted in the Wall      Street Journal on the last business day of the reporting      period. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.6   | No Reduction by Taxes or Other      Charges. Royalties earned on sales occurring in any country outside      the United States may not be reduced by any taxes, fees, or other charges      imposed by the government of such country on the payment of royalty      income.  LICENSEE is responsible for all bank transfer      charges.  Notwithstanding this, all payments made by LICENSEE in      fulfillment of UNIVERSITY’s own tax liability in any particular country      will be credited against earned royalties or fees due UNIVERSITY for that      country. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.7   | Prompt Remittance on Foreign      Sales. If at any time, legal restrictions prevent the prompt      remittance of royalties by LICENSEE from any country where Licensed      Products are sold or Licensed Method is practiced, LICENSEE shall convert      the amount owed to UNIVERSITY into United States funds and shall pay      UNIVERSITY directly from its U.S. source of funds for as long as the legal      restrictions apply. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.8   | Timing of Royalty      Accrual. Royalties accruing to UNIVERSITY shall be owed by LICENSEE      to UNIVERSITY when Licensed Product or Licensed Method are invoiced, or if      not invoiced, when delivered, provided or performed to or for a third      party. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.9   | Interest on Late      Payments. In the event that any payments are not received when due,      LICENSEE shall pay additional interest charges on overdue balances in a      period at a daily compounded annual rate of the prime rate quoted in the      Wall Street      Journal on the last business day of the reporting period plus      10%.  Interest shall be calculated from the date payment was due      and until actually received byUNIVERSITY. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.10   | Record Keeping, Inspection and      Audit. LICENSEE shall maintain accurate books and records      concerning this Agreement , and, upon reasonable advance notice by      UNIVERSITY, LICENSEE’s records, inventory, and Licensed Product production      or Licensed Method practice facilities shall be open for inspection by      UNIVERSITY or University’s duly authorized agents for the purpose of      verifying the accuracy of reports, including but not limited to      calculations, deductions and payments due.  LICENSEE shall keep,      and cause any sublicensee(s) to keep, accurate records and books showing      the maintenance, production, inventory, sale, distribution or sublicensing      of Licensed Product and the performance of Licensed      Method.  LICENSEE shall permit UNIVERSITY or duly authorized      agents of UNIVERSITY, during regular business hours, to inspect LICENSEE      facilities and records for the purpose of verifying the accuracy of      reports, quality control and auditing royalty payments due      UNIVERSITY.  In the event payment is in error by Ten Thousand      U.S. Dollars ($10,000.00) or more, LICENSEE shall pay all reasonable      documented audit expenses. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.11   | Invalidity. If any      patent or patent claim within Patent Rights is held invalid in a final      decision by a court of competent jurisdiction and last resort from which      no appeal has or can be taken, all obligation to pay royalties based on      that patent or claim or any claim patentably indistinct therefrom will      cease as of the date of final decision.  LICENSEE shall not,      however, be relieved from paying any royalties that accrued before the      final decision, that are based on another patent or claim not involved in      the final decision, or that are based on UNIVERSITY’s property      rights. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.1   | Patent Prosecution.      UNIVERSITY maintain the Patent Rights at LICENSEE’s      expense.  UNIVERSITY shall provide all patent correspondence to      LICENSEE and LICENSEE shall have opportunity to review and make timely      comment. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.2   | Patent Marking. LICENSEE      and sublicensee(s) shall mark Licensed Product with the patent numbers of      the patents within Patent Rights in accordance to 35 U.S.C. Section 287      (or its foreign equivalents) to reflect that unauthorized production, use,      sale, and distribution areprohibited. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.3   | Infringement      Notification. LICENSEE shall notify UNIVERSITY promptly of any      known production, sale, marketing, distribution, or use of Licensed      Product or the performance of Licensed Method by persons that are not      authorized to produce, use, market, distribute, or sell Licensed Product      or Licensed Method.  Notification of such infringement shall      include reasonable details that would enable UNIVERSITY to investigate and      terminate such infringement, and UNIVERSITY retains the right to terminate      such infringement subject to this Article5. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.4   | Empowerment of LICENSEE      Concerning Infringements. Pursuant to this Agreement and to the      provisions of 35 U.S.C. Chapter 29 or other statutes, LICENSEE is      empowered: |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.4.a   | to      bring suit in its own name, at its own expense, and on its own behalf for      infringement of presumably valid claims in Patent Rights,    and |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.4.b   | in      any such suit, to enjoin infringement and to collect for its use, damages,      profits, and awards of whatever nature recoverable for such infringement,      and |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.4.c   | in      any such suit, to settle any claim or suit for infringement of Patent      Rights with the prior written permission of UNIVERSITY, such permission      not to be unreasonably withheld, |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 5.5   | Recoveries when University      Shares Costs. If UNIVERSITY notifies LICENSEE that UNIVERSITY      agrees to bear one-half of expenses as specified in Paragraph 5.4, and if      UNIVERSITY pays LICENSEE from time to time as expenses are incurred, then      all recoveries obtained in such suit shall be divided equally between      LICENSEE and UNIVERSITY. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.6   | Suits Brought By      University. In the event that suit is brought by UNIVERSITY under      this Article, UNIVERSITY agrees that LICENSEE may join UNIVERSITY as a      party plaintiff in any such suit. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.7   | Bearing of Expenses. In      any infringement action commenced under this Article, provided that      UNIVERSITY fails to notify LICENSEE, as provided in Paragraph 5.4, that      UNIVERSITY agrees to bear one-half of the expense of prosecuting such      suit, the expenses in such action, including, but not limited to, costs,      fees, attorney fees, and disbursements, shall be paid solely by      LICENSEE. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.8   | UNIVERSITY Cooperation.      UNIVERSITY shall cooperate fully with LICENSEE in connection with any      infringement action initiated by LICENSEE under this Article, and      UNIVERSITY agrees promptly to provide reasonable access to all necessary      documents and to render reasonable assistance in response to a written      request by LICENSEE. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.9   | In The Event Of A Declaratory      Judgment. In the event that a declaratory judgment action alleging      invalidity or non-infringement of any of the patents included in Patent      Rights shall be brought against LICENSEE or raised by way of counterclaim      or affirmative defense in an infringement suit brought by LICENSEE under      this Article, LICENSEE, pursuant to this Agreement and to 35 U.S.C.      Chapter 29 or other statutes, isempowered: |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.9.a   | to      defend the suit in its own name, at its own expense, and on its own      behalf, for presumably valid claims in such patents;  and |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------|

| 5.9.b   | in      any such suit to enjoin infringement and to collect for its use, damages,      profits, and awards of whatever nature recoverable for such infringement;      and |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.9.c   | in      any such suit to settle any claim or suit for declaratory judgment      involving Patent Rights with the prior written permission of UNIVERSITY,      such permission not to be unreasonablywithheld. |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 5.10   | Damage Recovery. In the      event that UNIVERSITY does not participate according to Paragraph 5.4 in      any action brought under this Article and LICENSEE recovers damages,      LICENSEE shall pay to UNIVERSITY an earned royalty on such recovery, the      amount of such royalty to be equal to that specified in Article 3 and to      be payable as specified under Article4. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.11   | No Obligation to Bring      Suit. Nothing contained within this Article or this Agreement shall      be construed to obligate UNIVERSITY to bring any suit or to enforce any      rights under this Agreement.  Additionally, nothing contained      within this Article or this Agreement shall be construed to limit the      ability of UNIVERSITY to bring any suit or to enforce any rights under      this Agreement. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.1   | Obligation to      Commercialize. LICENSEE shall, using best business practice,      diligently fill the market demands for Licensed Products and Licensed      Method within the Field of Use and in the  Territory. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.2   | Approvals or      Certifications. LICENSEE shall diligently endeavor to obtain all      necessary governmental approvals for the manufacture, use, marketing,      sale, and distribution of Licensed Products and/or performance of Licensed      Method. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.3   | Diligence Timelines.      LICENSEE shall: |
|-----------------|-------------------------------------------|

| 6.3.a   | market      Licensed Products for sale, or Licensed Method for performance, in the      Territory and the within the Field of Use by December 31, 2010;      and |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.3.b   | market      Licensed Products for sale and Licensed Method for performance within the      Field of Use within sixty (60) days of regulatory approval by the      appropriate governmental agency in each country in the      Territory. |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.1   | Term. This Agreement      shall be in effect as of the Effective Date, and shall continue until the      last-to-expire Patent Rights. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------|

| 7.2   | Termination by LICENSEE.      LICENSEE may terminate this Agreement, at any time, upon ninety (90) days      prior written notice to UNIVERSITY and including in the notice a      declaration that LICENSEE is no longer, and henceforth will not be, making      commercial gain from the Patent Rights or Technical Information for      Licensed Product. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.3   | Termination by UNIVERSITY.      If LICENSEE breaches any term of this Agreement, then UNIVERSITY      may give written notice of the breach; and, if LICENSEE fails to correct      the breach within sixty (60) days, then UNIVERSITY shall have the right to      cancel or terminate this Agreement.  This right, if exercised by      UNIVERSITY, supersedes the rights granted in Article  2. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 7.4   | Automatic Termination.      This Agreement will terminate automatically if, during the term of this      Agreement, LICENSEE: |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------|

| 7.4.a   | commits      any act of bankruptcy; or |
|-------------------|----------------------------------------|

| 7.4.b   | becomes      insolvent; or |
|-------------------|----------------------------|

| 7.4.c   | is      unable to pay its debts as they become due;or |
|-------------------|-------------------------------------------------------|

| 7.4.d   | files      a petition under any bankruptcy or insolvency act;  or |
|-------------------|-------------------------------------------------------------------|

| 7.4.e   | has      a petition under any bankruptcy or insolvency act filed against it which      is not dismissed within sixty (60) days;or |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------|

| 7.4.f   | offers      any component of  Patent Rights for the benefit of its      creditors; or |
|-------------------|-------------------------------------------------------------------------------------------------|

| 7.4.g   | terminates      its incorporation. |
|-------------------|------------------------------------|

| 7.5   | Termination by UNIVERSITY.      UNIVERSITY shall have the right, at its sole discretion, to      terminate this Agreement if, during the term of this Agreement,      LICENSEE: |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.5.a   | ceases      the commercial sale of Licensed Product or performance of Licensed Method;      or |
|-------------------|------------------------------------------------------------------------------------------------|

| 7.5.b   | liquidates      or takes steps to liquidate its assets reasonably required for the sale of      Licensed Product or the performance of Licensed  Method. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.6   | Effect of Termination.      Upon termination of this Agreement for any reason, LICENSEE shall      immediately cease use of the rights granted herein, including but not      limited to ceasing to transfer Licensed Products and practice Licensed      Method; all Licensed Product under the control of LICENSEE and/or      sublicensee(s) shall be fully and completely destroyed by LICENSEE using      appropriate chemical and/or mechanical methods, excepting Licensed Product      stock held by sublicensee(s) that remains in compliance with the terms and      conditions of this Agreement. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.7   | Effect of Termination Upon      Sublicenses. Upon termination of this Agreement for any reason,      UNIVERSITY, at its sole discretion, shall determine whether sublicenses      shall be canceled or assigned to UNIVERSITY.  LICENSEE agrees to      assign to UNIVERSITY if requested byUNIVERSITY. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.8   | No Relief of Obligations      Incurred Prior to Termination. Termination of the Agreement granted      hereunder for any reason by either party shall not relieve the parties of      any obligation accruing prior to such  termination. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.9   | Surviving      Terms.  Notwithstanding any termination or expiration of      this Agreement, the provisions of Articles 9, 10 and 11 shall survive and      shall be enforceable according to the terms  thereof. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 8.1   | UNIVERSITY Assignments.      UNIVERSITY may assign thisAgreement. |
|-----------------|-------------------------------------------------------------------|

| 8.2   | Other Assignments. This      Agreement shall not be assigned by LICENSEE  except: |
|-----------------|-----------------------------------------------------------------------------------|

| 8.2.a   | With      the prior written consent of UNIVERSITY, which consent shall not be      unreasonably withheld; or as part of a sale or transfer of substantially      the entire business of LICENSEE relating to operations which concern this      Agreement, and that a condition of such sale is purchaser’s agreement to      comply with the terms and conditions of this  Agreement. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.2.b   | Assignment      of this Agreement under this Article shall only become effective after      UNIVERSITY receives written notice by the Party making the assignment to      the other Party that: |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.2.b.i   | The      assignment has been made; |
|---------------------|------------------------------------|

| 8.2.b.ii   | The      name of the new assignee; |
|----------------------|------------------------------------|

| 8.2.b.iii   | Any      breaches have been cured and payments due paid;  and |
|-----------------------|---------------------------------------------------------------|

| 8.2.b.iv   | The      new recipient of notices and other necessary information required under      Article 12. |
|----------------------|---------------------------------------------------------------------------------------------------|

| 9.1   | Information Handling.      LICENSEE shall safeguard confidential Technical Information (“Confidential      Information”) supplied by UNIVERSITY against disclosure to others with the      same degree of care as it exercises with its own data or information of a      similar nature.  LICENSEE shall not use such Confidential      Information except to perform its obligations under this Agreement, and      shall not disclose such Confidential Information to others (except to its      employees, agents, or consultants who are bound to LICENSEE by a like      obligation of confidentiality) without the express written permission of      UNIVERSITY, except that LICENSEE is not prevented from using or disclosing      any of the Confidential Informationthat: |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.1.a   | LICENSEE      can demonstrate by written records was previously known to it;      or |
|-------------------|--------------------------------------------------------------------------------------|

| 9.1.b   | is      now or becomes in the future public knowledge other than through acts or      omissions of LICENSEE; or |
|-------------------|-----------------------------------------------------------------------------------------------------------------|

| 9.1.c   | is      lawfully obtained by LICENSEE from sources independent of UNIVERSITY      without obligation of confidentiality;or |
|-------------------|----------------------------------------------------------------------------------------------------------------------------|

| 9.1.d   | is      required to be disclosed to a third party by applicable laws or out of      court proceedings. |
|-------------------|--------------------------------------------------------------------------------------------------------|

| 9.2   | Term of secrecy. The      secrecy obligations of LICENSEE under these terms shall remain in effect      for five (5) years from the termination date of this      Agreement. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.3   | No Reduction of Obligations Due      to Timing of Receipt of Technical Information. The obligations of      confidentiality and limited use hereunder apply to any Confidential      Information of UNIVERSITY provided to LICENSEE relating to the subject      matter of this Agreement, whether supplied under this Agreement or prior      to the Effective Date. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 9.4   | Arizona Public Records Law.      This Agreement itself cannot be Proprietary Information per the      Arizona Public Records Law A.R.S. 39-121 and A.R.S.    41-1350. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.1   | EXCEPT AS OTHERWISE EXPRESSLY      SET FORTH IN THIS AGREEMENT, UNIVERSITY MAKES NO REPRESENTATIONS AND      EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING,      BUT NOT LIMITED TO, WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR      PURPOSE, AND VALIDITY OF PATENTED RIGHTS CLAIMS, ISSUED OR      PENDING.  IT IS AGREED THAT LICENSEE ACCEPTS LICENSED PRODUCTS      AND LICENSED METHODS ON AN “AS IS”BASIS. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.2   | NOTHING      IN THIS AGREEMENT, EITHER EXPRESS OR IMPLIED, OBLIGATES UNIVERSITY EITHER      TO BRING OR TO PROSECUTE ACTIONS OR SUITS AGAINST THIRD PARTIES FOR PATENT      INFRINGEMENT OR TO FURNISH ANY KNOW-HOW OR TRADE SECRETS NOT PROVIDED IN      UNIVERSITY’S PATENT RIGHTS. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.3   | IN      NO EVENT SHALL UNIVERSITY BE LIABLE FOR DAMAGES OF ANY KIND INCLUDING      INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES RESULTING FROM THE EXERCISE      OF THIS LICENSE OR THE USE OF THE TECHNICAL INFORMATION OR LICENSED      PRODUCTS. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.4   | NO      WARRANTY OR REPRESENTATION IS MADE THAT ANYTHING MADE, USED, OR SOLD UNDER      THE TERMS OF THIS AGREEMENT WILL BE FREE FROM INFRINGEMENT OF ANY THIRD      PARTY PATENTS. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.5   | THIS      AGREEMENT DOES NOT CONFER BY IMPLICATION, ESTOPPEL, OR OTHERWISE ANY      LICENSE OR RIGHTS TO ANY OTHER PATENT OF UNIVERSITY OTHER THAN PATENT      RIGHTS AS EXPRESSLY STATED HEREIN, REGARDLESS OF WHETHER SUCH PATENTS ARE      DOMINANT OR SUBORDINATE TO PATENTRIGHTS. |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.1   | LICENSEE Warranties and      Representations. LICENSEE warrants and represents    that: |
|------------------|-----------------------------------------------------------------------------------------|

| 11.1.a   | The      production, use, marketing, sale, and distribution of Licensed Products      and the practice of Licensed Method shall be in conformance to applicable      county, state, federal or foreign laws, rules, and regulations governing      the production, use, marketing, sale, and distribution of Licensed      Products or the practice of Licensed Method in or between any county,      state, federal, or foreign jurisdiction;and |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.1.b   | Licensed      Products will not be produced, used, marketed, sold, distributed, and/or      sublicensed outside the Field of Use or Territory and that Licensed Method      will not be practiced outside the Field of Use or    Territory. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 11.2   | LICENSEE Representations,      Warranties and Indemnification. LICENSEE shall indemnify, hold      harmless and defend UNIVERSITY, its officers, employees, agents, and the      inventors of the Technical Information leading to patents and patent      applications in Patent Rights and their employers, against any and all      claims, suits, losses, damage, costs, fees, and expenses resulting from or      arising out of the exercise of this Agreement or any sublicense, and those      arising from the breach or non-performance by LICENSEE, of the foregoing      obligations, representations and warranties.  This      indemnification includes, but is not limited to, any product      liability. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.3   | Insurance Requirements.      LICENSEE, at its sole cost and expense, shall insure its activities in      connection with the work under this Agreement and obtain, keep in force,      and maintain insurance as follows, or an equivalent program of self      insurance: |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.3.a   | Comprehensive      or commercial general liability insurance (contractual liability included)      with its minimum limits as follows: |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------|

| 11.3.a.i   | Each      Occurrence One Million U.S. Dollars($1,000,000) |
|----------------------|-----------------------------------------------------------|

| 11.3.a.ii   | Products/Completed      Operations Aggregate Two Million U.S. Dollars  ($2,000,000) |
|-----------------------|-------------------------------------------------------------------------------------|

| 11.3.a.iii   | Personal      and Advertising Injury One Million U.S. Dollars    ($1,000,000) |
|------------------------|-------------------------------------------------------------------------------|

| 11.3.a.iv   | General      Aggregate (commercial form only) Two Million U.S. Dollars      ($2,000,000) |
|-----------------------|------------------------------------------------------------------------------------------|

| 11.3.b   | The      coverage and limits specified above do not in any way limit the liability      of LICENSEE under this Agreement.  Such insurance coverage is      required prior to the first sale of Licensed Products or performance of      Licensed Method.  LICENSEE shall furnish UNIVERSITY with      certificates of insurance showing compliance with all      requirements.  Such certificatesmust: |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.3.b.i   | Provide      for thirty (30) day advance written notice to UNIVERSITY of any      modification. |
|----------------------|-------------------------------------------------------------------------------------------------|

| 11.3.b.ii   | Indicate      that UNIVERSITY has been endorsed as an additional Insured under the      coverage specified above. |
|-----------------------|-------------------------------------------------------------------------------------------------------------------|

| 11.3.b.iii   | Include      a provision that the coverage will be primary and will not relate to nor      will be excess over any valid and collectable insurance or program of      self-insurance carried or maintained by  UNIVERSITY. |
|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.4   | Notification Concerning Suits      Under This Article. UNIVERSITY shall notify LICENSEE in writing of      any claim or suit brought against UNIVERSITY in respect of which      UNIVERSITY intends to invoke the provisions of this      Article.  LICENSEE shall promptly keep UNIVERSITY informed on a      current basis of its defense of any claims under this    Article. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 12. | NOTICES |
|-----|---------|

| 12.1   | Delivery. Any royalty or      fee payment, notice, or other communication required or permitted to be      made or to be given to either party under this Agreement shall be      sufficiently made or given on the date of mailing if sent to such party by      either certified first class U.S. mail, postage prepaid, or by traceable      delivery services such as Federal Express, United Postal Service or DHL,      addressed to that party at its address set forth  below: |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13. | MISCELLANEOUS |
|-----|---------------|

| 13.1   | Use of Namesand Trademarks. Nothing      contained in this Agreement confers any right to use in advertising,      publicity, or other promotional activities any name, trade name,      trademark, or other designation of any party hereto (including      contraction, abbreviation, or simulation of any of the      foregoing).  Unless required by law, the use by LICENSEE of the      name “Arizona Board of Regents”, “The University of Arizona”, or the name      of any campus associated with UNIVERSITY in advertising, publicity, or      other promotional activities isprohibited. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.2   | Governing Law and Venue.      This Agreement is subject to and shall be construed and enforced in      accordance with the laws of the State of Arizona, but the scope and      validity of any patent or patent application shall be governed by the      applicable laws of the country where the patent or patent application is      filed. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.3   | Entire Understanding.      This Agreement embodies the entire understanding of the parties, and there      are no other agreements or understandings, either express or implied,      between the parties relating to the subject matter hereof.  No      amendment or modification of this Agreement shall be valid or binding upon      the parties unless made in writing and signed on behalf of each of the      parties by their respective duly authorized officers or      agents. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.4   | Headings Provided For      Convenience. The headings of the Articles and certain paragraphs      are inserted for convenience of reference only and are not intended to be      a part of or affect the meaning or interpretation of this      Agreement. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.5   | U.S. Manufacture.      LICENSEE shall ensure compliance with Title 35 U.S.C.  §204. |
|------------------|------------------------------------------------------------------------------------------|

----

| 13.6   | Government Reporting      Requirements or Approvals. LICENSEE shall notify UNIVERSITY if      LICENSEE becomes aware that this Agreement is subject to any U.S. or      foreign government reporting or approval requirement.  LICENSEE      shall make all necessary filings and pay all costs including, but not      limited to, fees, penalties, and all other out-of-pocket costs associated      with such reporting or approvalprocess. |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.7   | Export Control. LICENSEE      shall observe all applicable United States and foreign laws with respect      to the transfer of Licensed Products or Licensed Method and related      technical data to foreign countries, including, without limitation, the      Export Administration Regulations. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.8   | Enforceability of Terms.      In case any of the provisions contained in this Agreement is held to be      invalid, illegal, or unenforceable in any respect, that invalidity,      illegality, or unenforceability will not affect any other provisions of      this Agreement, and this Agreement will be construed as if the invalid,      illegal, or unenforceable provisions had never been contained in      it. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.9   | State      of Arizona Required Clauses. |
|------------------|-----------------------------------------|

| 13.9.a   | The      parties agree to be bound by applicable state and federal rules governing      equal employment opportunity, immigration and      nondiscrimination. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.9.b   | The      parties agree that should a dispute arise between them, in any manner,      concerning this Agreement, and said dispute involves the sum of Fifty      Thousand U.S. Dollars ($50,000) or less in money damages only, exclusive      of interest or cost of attorney’s fees, the parties will submit the matter      to binding arbitration pursuant to the Arizona Supreme Court Rules for      Compulsory Arbitration and the decision of the arbitrator(s) shall be      final and binding upon the parties. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.9.c   | The      parties recognize that the performance by the UNIVERSITY may be dependent      upon the appropriation of funds by the State Legislature of      Arizona.  Should the State Legislature of Arizona fail to      appropriate the necessary funds, the UNIVERSITY may cancel this Agreement      without further duty or obligation. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.9.d   | This      Agreement is subject to the provisions of A.R.S. § 38-511.  The      UNIVERSITY may cancel this Agreement by written notice to the parties if      any person substantially involved in obtaining, drafting, or procuring      this Agreement for or on behalf of the UNIVERSITY becomes an employee or      consultant in any capacity ofLICENSEE. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.10   | Performance. The failure      of any party hereto at any time or times to require performance of any      provisions of this Agreement shall in no manner affect its right to      enforce such provision at a latertime. |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.11   | No Waiver.  No      waiver by any party of this Agreement of any breach or default of any of      the covenants or agreements herein set forth may be deemed a waiver as to      any subsequent and/or similar breach ordefault. |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.12   | Parties.  The      parties are not partners or joint venturers, and nothing herein shall be      construed as causing them to be.  Neither of the parties has the      authority to act in the other’s name, nor act for the other’s benefit,      except as is expressly provided in this  Agreement. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.13   | Complete      Agreement.  This Agreement constitutes the entire      agreement, both written and oral, between the parties.  All      prior agreements relating to the subject matter of this Agreement, whether      written or oral, express or implied, are  cancelled. |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| A.1.   | U.S.      Patent No. 7,015,052, issued on March 21, 2006, entitled "Screen-Printing      Techniques for the Fabrication of Organic Light-Emitting Diodes" and any      and all U.S. issued patents or patent applications that may be derived      therefrom " |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|